Sebla B. Kutluay
- Virology top 0.5%
- Molecular Biology top 10%
- Immunology top 5%
- Infectious Diseases top 5%
- Epidemiology top 10%
- Co-authors
- Paul D. BieniaszSteven J. TriezenbergTrinity ZangSam J. WilsonM. ErrandoThéodora HatziioannouJohn W. SchogginsCharles M. Rice
- Topics
- HIV Research and Treatment (17 papers)HIV/AIDS drug development and treatment (8 papers)RNA Research and Splicing (7 papers)
- Partner nations
- United StatesRussiaUnited Kingdom
In The Last Decade
Sebla B. Kutluay
31 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Virology 899
- Molecular Biology 860
- Immunology 522
- Infectious Diseases 504
- Epidemiology 394
Countries citing papers authored by Sebla B. Kutluay
This map shows the geographic impact of Sebla B. Kutluay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebla B. Kutluay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebla B. Kutluay more than expected).
Fields of papers citing papers by Sebla B. Kutluay
This network shows the impact of papers produced by Sebla B. Kutluay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebla B. Kutluay. The network helps show where Sebla B. Kutluay may publish in the future.
Co-authorship network of co-authors of Sebla B. Kutluay
This figure shows the co-authorship network connecting the top 25 collaborators of Sebla B. Kutluay. A scholar is included among the top collaborators of Sebla B. Kutluay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebla B. Kutluay. Sebla B. Kutluay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 6 | |
| 3 | 112 | |
| 4 | 41 | |
| 5 | 15 | |
| 6 | 29 | |
| 7 | 7 | |
| 8 | 60 | |
| 9 | 12 | |
| 10 | 45 | |
| 11 | 94 | |
| 12 | 11 | |
| 13 | 199 | |
| 14 | 29 | |
| 15 | 76 | |
| 16 | MX2 is an interferon-induced inhibitor of HIV-1 infectionbreakdown → | 395 |
| 17 | 47 | |
| 18 | 151 | |
| 19 | 29 | |
| 20 | 134 |
About Sebla B. Kutluay
Sebla B. Kutluay is a scholar working on Virology, Infectious Diseases and Immunology, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (8 papers) and RNA Research and Splicing (7 papers). The work is most often cited by research in Virology (899 citations), Infectious Diseases (504 citations) and Immunology (522 citations). Sebla B. Kutluay has collaborated with scholars based in United States, Russia and United Kingdom. Frequent co-authors include Paul D. Bieniasz, Steven J. Triezenberg, Trinity Zang, Sam J. Wilson, M. Errando, Théodora Hatziioannou, John W. Schoggins, Charles M. Rice, Julia Bitzegeio and Shalini S. Yadav. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.